title: Porcine fetal ventral mesencephalic cells are targets for primed xenoreactive human T cells.
abstract: Xenotransplantation of porcine fetal ventral mesencephalic (pfVM) cells to overcome the dopamine shortage in the striatum of patients with Parkinson's disease seems a viable alternative to allotransplantion of human fetal donor tissue, especially because the latter is complicated by both practical and ethical issues. There is, however, little known about the xenospecific immune responses involved in such an intracerebral xenotransplantation. The aim of our study was to investigate whether (1) naive human peripheral blood mononuclear cells (PMBC) display cytotoxicity against pfVM cells of E28 pig fetuses, and (2) priming of human PBMC by xenogeneic antigen presenting cells (APC) modulates pfVM-directed cellular cytotoxicity. For this purpose fresh PMBC from nine individual donors were primed by incubation with either irradiated pfVM cells or porcine spleen cells (PSC) as APC in the presence of IL-2 for 1 week before assessing cytotoxicity in a 51Cr release assay. Also, direct NK reactivity and antibody-dependent cellular cytotoxicity (ADCC) of fresh PMBC against pfVM cells was assessed. No direct cytotoxicity of naive cells (either NK reactivity or ADCC) against pfVM cells could be determined. Only PMBC primed with PSC were capable of lysing pfVM cells. PBMC primed with pfVM cells did not show cytolytic capacity towards pfVM. Interestingly, large differences in xenospecific T-cell responses exist between individual donor PBMC. Thus, human T cells are capable of killing pfVM cells in a xenoreactive response, but only after priming by donor APC. The large interindividual differences between human donors in their xenoreactive response may influence patient selection for xenotransplantation and chances of graft survival for individual patients.
authors.affiliation: Department of Neurosurgery, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. J.Koopmans@nchir.umcg.nl
authors.forename: Jan
authors.initials: J
authors.lastname: Koopmans
authors.forename: Aalzen
authors.initials: A
authors.lastname: de Haan
authors.forename: Elinda
authors.initials: E
authors.lastname: Bruin
authors.forename: Ieneke
authors.initials: I
authors.lastname: van der Gun
authors.forename: Henk
authors.initials: H
authors.lastname: van Dijk
authors.forename: Jan
authors.initials: J
authors.lastname: Rozing
authors.forename: Lou
authors.initials: L
authors.lastname: de Leij
authors.forename: Michiel
authors.initials: M
authors.lastname: Staal
mesh_terms: D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity / Q000502:physiology; D000938:Antigen-Presenting Cells / Q000378:metabolism; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods; D016332:Fetal Tissue Transplantation / Q000276:immunology* / Q000379:methods; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000378:metabolism / Q000502:physiology; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008636:Mesencephalon / Q000166:cytology / Q000276:immunology*; D013552:Swine; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D014183:Transplantation, Heterologous
chemical_list: D007376:Interleukin-2